Carregant...
Update on systemic treatment for newly diagnosed inflammatory breast cancer
BACKGROUND: Inflammatory breast cancer (IBC) is a rare and aggressive disease, accounting for 2–4% of new cases of breast cancer. Owing to its aggressive nature, IBC represent approximately 8–10% of breast cancer deaths. Management of IBC requires a multidisciplinary team for decision-making involvi...
Guardat en:
| Publicat a: | J Adv Res |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8020152/ https://ncbi.nlm.nih.gov/pubmed/33842000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jare.2020.08.014 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|